共 135 条
[1]
McKenna WJ(2017)Classification, Epidemiology, and Global Burden of Cardiomyopathies Circ Res 121 722-730
[2]
Maron BJ(2021)Diagnostic work-up of cardiac amyloidosis using cardiovascular imaging: current standards and practical algorithms Vasc Health Risk Manag 17 661-673
[3]
Thiene G(1971)Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses Science 172 1150-1151
[4]
Korosoglou G(2020)Prevalence of cardiac amyloidosis among adult patients referred to tertiary centres with an initial diagnosis of hypertrophic cardiomyopathy Int J Cardiol 300 191-195
[5]
Giusca S(2023)Epidemiology of cardiac amyloidosis in Germany: a retrospective analysis from 2009 to 2018 Clin Res Cardiol 112 401-408
[6]
Andre F(2023)Therapeutic value of tafamidis in patients with wild-type transthyretin amyloidosis (ATTRwt) with cardiomyopathy based on cardiovascular magnetic resonance (CMR) imaging Clin Res Cardiol 112 353-362
[7]
Glenner GG(2016)T1 Mapping in characterizing myocardial disease: a comprehensive review Circ Res 119 277-299
[8]
Terry W(2021)Multi-parametric assessment of left ventricular hypertrophy using late gadolinium enhancement, T1 mapping and strain-encoded cardiovascular magnetic resonance J Cardiovasc Magn Reson 23 92-461
[9]
Harada M(2013)End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases Nephrol Dial Transplant 28 455-1448
[10]
Isersky C(2012)Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis Heart 98 1442-1072